SCHEMBL23960949

SCHEMBL23960949

COC(=O)c1ncc(N2CCN(C)CC2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.46
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ HTR6 P50406 2/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ HTR3A P46098 1/20 0.41
▸ VNN1 O95497 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ GAA P10253 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CHEK1 O14757 1/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23536740 0.83 CHRNB2 (0.48) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL23960950 0.81 CHEK1 (0.48) NPC1RAB9AKMT2AHDAC3HDAC8
Hydrochloric Acid SCHEMBL25241141 0.81 CHRNB2 (0.47) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL64453 0.80 HRH3 (0.54) SIRT6NPC1RAB9AKMT2AHTR6
SCHEMBL26115242 0.79 OPRK1 (0.40) NPC1RAB9AKMT2AKDM4E
SCHEMBL23536683 0.79 GPR119 (0.53) KMT2AALDH1A1MEN1MAPTLMNA
SCHEMBL32670375 0.76 CYP4F2 (0.39) NPC1RAB9AKMT2AMAPT
SCHEMBL1950805 0.76 TP53BP1 (0.51) NPC1RAB9AKMT2AALDH1A1VNN1
SCHEMBL64090 0.74 HDAC3 (0.57) NPC1RAB9AKMT2AHDAC3HDAC8
SCHEMBL65696 0.73 ALDH1A1 (0.71) SIRT6NPC1RAB9AKMT2AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332036-A1 PYRIMIDINE AND PYRAZINE HDAC1,2 INHIBITORS REGENACY PHARMACEUTICALS LLC (US) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332036-A1 PYRIMIDINE AND PYRAZINE HDAC1,2 INHIBITORS HDAC1, HDAC2, HDAC11 SIRT6 463/4885NPC1 1369/4885RAB9A 3718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback